Effects of 15-deoxy-delta12,14-prostaglandin J2 on cell proliferation and apoptosis in ECV304 endothelial cells

Acta Pharmacol Sin. 2004 Jan;25(1):47-53.

Abstract

Aim: To investigate the effects of 15-deoxy-delta12,14-prostaglandin J2 (15d-PGJ2) on cell proliferation and apoptosis in ECV304 endothelial cells and related molecular mechanism.

Methods: MTT, Hoechst33258, TUNEL, Flow cytometry, DNA ladder, RT-PCR, Western blot, and electrophoretic mobility shift assay (EMSA) analysis were employed.

Results: The 15d-PGJ2 induced apoptosis in ECV304 endothelial cells in a dose-dependent manner (the percentage of apoptosis was enhanced from 10.0 %+/-1.3 % to 32.8 %+/-1.6 %), which was accompanied by inhibition of NF-?B and AP-1 DNA binding activity, down-regulation of c-myc, upregulation of Gadd45 and p53, and activation of p38 kinase. However, the expression of p21 was found no significant change.

Conclusion: peroxisome proliferator-activated receptor gamma ligand, 15d-PGJ2, can inhibit proliferation and induce apoptosis in ECV304 endothelial cells through different mechanisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cell Division / drug effects
  • Cells, Cultured
  • Endothelial Cells / metabolism*
  • Humans
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / metabolism
  • Prostaglandin D2 / analogs & derivatives
  • Prostaglandin D2 / pharmacology*
  • Proto-Oncogene Proteins c-myc / metabolism
  • Transcription Factor AP-1 / metabolism
  • Tumor Suppressor Protein p53 / metabolism
  • Umbilical Cord / cytology
  • p38 Mitogen-Activated Protein Kinases

Substances

  • 15-deoxy-delta(12,14)-prostaglandin J2
  • NF-kappa B
  • Proto-Oncogene Proteins c-myc
  • Transcription Factor AP-1
  • Tumor Suppressor Protein p53
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Prostaglandin D2